v3.25.2
Equity and Redeemable Non-controlling Interests - Schedule of Common Stock Outstanding shares (Details) - shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Class Of Stock [Line Items]      
Beginning balance 430,808,244 505,707,592 344,796,271
Common stock shares issued [1] 9,729,285 19,466,040 201,832,740
Distribution reinvestment plan shares issued 7,508,664 8,115,750 8,158,039
Common stock shares repurchased (46,307,277) (102,511,499) (49,115,155)
Independent directors' restricted stock grant [2] 33,797 30,361 35,697
Ending balance 401,772,713 430,808,244 505,707,592
Common Stock Class T      
Class Of Stock [Line Items]      
Beginning balance 5,282,025 5,721,496 4,648,436
Common stock shares issued [1] 230,764 98,898 1,112,055
Distribution reinvestment plan shares issued 142,951 141,944 125,187
Common stock shares repurchased (138,567) (482,517) (164,182)
Ending balance 5,055,645 5,282,025 5,721,496
Common Stock Class S      
Class Of Stock [Line Items]      
Beginning balance 195,023,616 224,556,910 154,381,036
Common stock shares issued [1] 209,158 4,915,057 80,943,605
Distribution reinvestment plan shares issued 3,660,648 3,788,883 3,647,656
Common stock shares repurchased (17,502,181) (38,237,234) (14,415,387)
Ending balance 181,391,241 195,023,616 224,556,910
Common Stock Class D      
Class Of Stock [Line Items]      
Beginning balance 27,512,551 30,974,173 22,142,299
Common stock shares issued [1] 293,126 153,390 10,500,831
Distribution reinvestment plan shares issued 500,536 335,712 720,473
Common stock shares repurchased (2,378,099) (3,643,944) (2,389,430)
Ending balance 25,928,114 27,512,551 30,974,173
Common Stock Class I      
Class Of Stock [Line Items]      
Beginning balance 202,990,052 244,455,013 163,624,500
Common stock shares issued [1] 9,457,765 14,803,271 109,276,249
Distribution reinvestment plan shares issued 3,204,529 3,849,211 3,664,723
Common stock shares repurchased (26,288,430) (60,147,804) (32,146,156)
Independent directors' restricted stock grant [2] 33,797 30,361 35,697
Ending balance 189,397,713 202,990,052 244,455,013
[1] Includes exchanges between share classes.
[2] The independent directors’ restricted stock grant represents $0.8 million, $0.8 million and $0.8 million of the annual compensation paid to the independent directors for the years ended December 31, 2024, 2023 and 2022, respectively. Each grant is amortized over the one-year service period of such grant.